Microbubbles as a contrast agent in grating interferometry mammography: an ex vivo proof-of-mechanism study
Abstract Grating interferometry mammography (GIM) is an experimental breast imaging method at the edge of being clinically implemented. Besides attenuation, GIM can measure the refraction and scattering of x-rays resulting in differential phase contrast (DPC) and dark-field (DF) images. In this expl...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2019-05-01
|
Series: | European Radiology Experimental |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s41747-019-0097-2 |
id |
doaj-dab2ce5acd414bdb8f5ffd2bf99e3fac |
---|---|
record_format |
Article |
spelling |
doaj-dab2ce5acd414bdb8f5ffd2bf99e3fac2020-11-25T02:57:41ZengSpringerOpenEuropean Radiology Experimental2509-92802019-05-01311610.1186/s41747-019-0097-2Microbubbles as a contrast agent in grating interferometry mammography: an ex vivo proof-of-mechanism studyKristina Lång0Carolina Arboleda1Serafino Forte2Zhentian Wang3Sven Prevrhal4Thomas Koehler5Norbert Kuhn6Bernd David7Konstantins Jefimovs8Rahel A. Kubik-Huch9Marco Stampanoni10Swiss Light Source, ETH Zurich, Paul Scherrer InstituteSwiss Light Source, ETH Zurich, Paul Scherrer InstituteDepartment of Radiology, Kantonsspital BadenSwiss Light Source, ETH Zurich, Paul Scherrer InstitutePhilips GmbH Innovative Technologies, Research Laboratories, Philips Research HamburgPhilips GmbH Innovative Technologies, Research Laboratories, Philips Research HamburgPhilips GmbH Innovative Technologies, Research Laboratories, Philips Research HamburgPhilips GmbH Innovative Technologies, Research Laboratories, Philips Research HamburgSwiss Light Source, ETH Zurich, Paul Scherrer InstituteDepartment of Radiology, Kantonsspital BadenSwiss Light Source, ETH Zurich, Paul Scherrer InstituteAbstract Grating interferometry mammography (GIM) is an experimental breast imaging method at the edge of being clinically implemented. Besides attenuation, GIM can measure the refraction and scattering of x-rays resulting in differential phase contrast (DPC) and dark-field (DF) images. In this exploratory study, we assessed the feasibility of using microbubbles as a contrast agent in GIM. Two millilitres of microbubbles and iodine were respectively injected into ex vivo breast phantoms, consisting of fresh chicken breasts. Native and postcontrast images were acquired with a clinically compatible GIM setup, operated at 38 kVp, 14-s acquisition time, and with a dose of 1.3 mGy. The visibility of the contrast agents was analysed in a side-by-side comparison by three radiologists. The contrast-to-noise-ratio (CNR) was calculated for each contrast agent. We found that both contrast agents were judged to be visible by the readers. The mean CNR was 3.1 ± 1.9 for microbubbles in DF and 24.2 ± 6.5 for iodine in attenuation. In conclusion, this is a first proof-of-mechanism study that microbubbles could be used as a contrast agent in clinically compatible GIM, due to their scattering properties, which implies the potential use of a contrast agent with a high safety profile in x-ray-based breast imaging.http://link.springer.com/article/10.1186/s41747-019-0097-2Contrast mediaInterferometryMammographyMicrobubblesPhantoms (imaging) |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Kristina Lång Carolina Arboleda Serafino Forte Zhentian Wang Sven Prevrhal Thomas Koehler Norbert Kuhn Bernd David Konstantins Jefimovs Rahel A. Kubik-Huch Marco Stampanoni |
spellingShingle |
Kristina Lång Carolina Arboleda Serafino Forte Zhentian Wang Sven Prevrhal Thomas Koehler Norbert Kuhn Bernd David Konstantins Jefimovs Rahel A. Kubik-Huch Marco Stampanoni Microbubbles as a contrast agent in grating interferometry mammography: an ex vivo proof-of-mechanism study European Radiology Experimental Contrast media Interferometry Mammography Microbubbles Phantoms (imaging) |
author_facet |
Kristina Lång Carolina Arboleda Serafino Forte Zhentian Wang Sven Prevrhal Thomas Koehler Norbert Kuhn Bernd David Konstantins Jefimovs Rahel A. Kubik-Huch Marco Stampanoni |
author_sort |
Kristina Lång |
title |
Microbubbles as a contrast agent in grating interferometry mammography: an ex vivo proof-of-mechanism study |
title_short |
Microbubbles as a contrast agent in grating interferometry mammography: an ex vivo proof-of-mechanism study |
title_full |
Microbubbles as a contrast agent in grating interferometry mammography: an ex vivo proof-of-mechanism study |
title_fullStr |
Microbubbles as a contrast agent in grating interferometry mammography: an ex vivo proof-of-mechanism study |
title_full_unstemmed |
Microbubbles as a contrast agent in grating interferometry mammography: an ex vivo proof-of-mechanism study |
title_sort |
microbubbles as a contrast agent in grating interferometry mammography: an ex vivo proof-of-mechanism study |
publisher |
SpringerOpen |
series |
European Radiology Experimental |
issn |
2509-9280 |
publishDate |
2019-05-01 |
description |
Abstract Grating interferometry mammography (GIM) is an experimental breast imaging method at the edge of being clinically implemented. Besides attenuation, GIM can measure the refraction and scattering of x-rays resulting in differential phase contrast (DPC) and dark-field (DF) images. In this exploratory study, we assessed the feasibility of using microbubbles as a contrast agent in GIM. Two millilitres of microbubbles and iodine were respectively injected into ex vivo breast phantoms, consisting of fresh chicken breasts. Native and postcontrast images were acquired with a clinically compatible GIM setup, operated at 38 kVp, 14-s acquisition time, and with a dose of 1.3 mGy. The visibility of the contrast agents was analysed in a side-by-side comparison by three radiologists. The contrast-to-noise-ratio (CNR) was calculated for each contrast agent. We found that both contrast agents were judged to be visible by the readers. The mean CNR was 3.1 ± 1.9 for microbubbles in DF and 24.2 ± 6.5 for iodine in attenuation. In conclusion, this is a first proof-of-mechanism study that microbubbles could be used as a contrast agent in clinically compatible GIM, due to their scattering properties, which implies the potential use of a contrast agent with a high safety profile in x-ray-based breast imaging. |
topic |
Contrast media Interferometry Mammography Microbubbles Phantoms (imaging) |
url |
http://link.springer.com/article/10.1186/s41747-019-0097-2 |
work_keys_str_mv |
AT kristinalang microbubblesasacontrastagentingratinginterferometrymammographyanexvivoproofofmechanismstudy AT carolinaarboleda microbubblesasacontrastagentingratinginterferometrymammographyanexvivoproofofmechanismstudy AT serafinoforte microbubblesasacontrastagentingratinginterferometrymammographyanexvivoproofofmechanismstudy AT zhentianwang microbubblesasacontrastagentingratinginterferometrymammographyanexvivoproofofmechanismstudy AT svenprevrhal microbubblesasacontrastagentingratinginterferometrymammographyanexvivoproofofmechanismstudy AT thomaskoehler microbubblesasacontrastagentingratinginterferometrymammographyanexvivoproofofmechanismstudy AT norbertkuhn microbubblesasacontrastagentingratinginterferometrymammographyanexvivoproofofmechanismstudy AT bernddavid microbubblesasacontrastagentingratinginterferometrymammographyanexvivoproofofmechanismstudy AT konstantinsjefimovs microbubblesasacontrastagentingratinginterferometrymammographyanexvivoproofofmechanismstudy AT rahelakubikhuch microbubblesasacontrastagentingratinginterferometrymammographyanexvivoproofofmechanismstudy AT marcostampanoni microbubblesasacontrastagentingratinginterferometrymammographyanexvivoproofofmechanismstudy |
_version_ |
1724709734609584128 |